Related Experiment Videos
[Castleman's disease]
Insights
Castleman's disease (CD) management was studied in 12 HIV-negative patients. Plasmocell CD is difficult to diagnose and lacks treatment, while the hyalinovascular variant shows good surgical outcomes.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Castleman's disease (CD) is a rare lymphoproliferative disorder with diverse clinical presentations.
- Understanding the distinct subtypes of CD is crucial for effective management and prognosis.
Purpose of the Study:
- To present original clinical experience in managing Castleman's disease (CD).
- To review existing literature data on CD management.
- To characterize histological and immunophenotypical features of different CD variants.
Main Methods:
- Retrospective analysis of 12 HIV-negative patients diagnosed with CD.
- Detailed histological and immunophenotypical characterization of CD subtypes.
- Review of literature data for comparative analysis.
Main Results:
- The study included 12 patients (age 18-51 years) with HIV-negative CD.
- CD subtypes observed were plasmocell (6 patients), mixed (2 patients), and hyalinovascular (4 patients).
- Three patients with plasmocell CD died from severe autoimmune anemia; patients with hyalinovascular CD achieved remission after surgical node removal.
Conclusions:
- Diagnosis of plasmocell CD requires exclusion of infections, autoimmune diseases, and lymphomas.
- Currently, no established therapy exists for the plasmocell variant of CD.
- Surgical management is effective for the hyalinovascular variant of CD.
Aim:
To describe original experience in management of Castleman's disease (CD) and review literature data.
Material And Methods:
Twelve cases of HIV-free CD in patients aged 18-51 years (mean age 36 years) are reported.
Results:
CD was plasmocell, mixed and hyalinovascular in 6, 2 and 4 patients, respectively. Histological and immunophenotypical characteristics of CD are detailed. Three patients with plasmocell CD died of severe autoimmune anemia. All the patients with hyalinovascular KD variant were treated surgically (enlarged lymph nodes were removed) and achieved remission.
Conclusion:
The diagnosis of plasmocell CD is made after exclusion of infections, collagenoses, autoimmune diseases and lymphomas. Therapy of plasmocell variant of CD has not been developed yet.
Related Concept Videos
Cirrhosis I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction